HLA-B27 polymorphism associated with disease in a New Zealand population

New Zealand Journal of Medical Laboratory Science

Volumn 64, Issue 3, 2010, Pages 78-84

  Stewart, Andrew G ^a  

^a National Tissue Typing Laboratory   (New Zealand)

Author keywords

Disease association; HLA B27; Spondylarthropathies; Subtypes; Uveitis

Indexed keywords

HLA B27 ANTIGEN;

ARTICLE; ASIAN; CAUCASIAN; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PREVALENCE; SPONDYLOARTHROPATHY;

EID: 78649351210     PISSN: 11710195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Rodey GE. HLA beyond tears introduction to human histocompatibility. De Novo, Inc. Durango, Co, 2000 1. www.ebi.ac.uk/imgt/hla last accessed 29/09/2009
2. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. ankylosing spondylitis and HL-A 27. Lancet 1973; 301: 904-7.
3. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of HL-A antigen, W27, with ankylosing spondylitis. New Eng J Med 1973; 288: 704-6.
4. Beckingsale AB, Davies J, Gibson JM, Rosenthal AR. Acute anterior uveitis, ankylosing spondylitis, back pain and HLA-B27. Br J Ophthalmol 1984; 68: 741-5.
5. Garcia-Fernandez S, Gonzalez S, Mina Blanco A, Martinez-Borra J, Blanco-Gelaz M, Lopez-Vazquez A, et al, New insights regarding HLA-B27 diversity in the Asian population. Tissue Antigens 2001; 58: 259-62.
6. Alaez C, Gazit E, Ibarrola B, Yaron M, Livneh A, Avishai O, et al. Distribution of HLA-B27 subtypes in ankylosing spondylitis in an Israeli population. Arch Med Res 2007; 38: 452-5.
7. Baech J, Schmidt-Olsen S, Steffensen R, Varming K, Grunnet N, Jersild C. Frequency of HLA-B27 subtypes in a Danish population and in Danish patients with ankylosing spondylitis. Tissue Antigens 1997; 49: 499-502.
8. Ben Radhia K, Ayed-Jendoubi S, Sfar I, Ben Romdhane T, Makhlouf M, Gorgi Y, et al. Distribution of HLA-.B.*27 subtypes in Tunisians and their association with ankylosing spondylitis. Joint Bone Spine 2008; 75: 172-5.
9. Birinci A, Bilgici A, Kuru O, Durupinar B. HLA-B27 polymorphism in Turkish patients with ankylosing spondylitis. Rheumatol Int 2006; 26: 285-7.
10. Mardjuadi A, Nasution AR, Kunmartini S, Lardy NM, Sudarsono D, Feltkamp TE. Clinical features of spondyloarthropathy in Chinese and native Indonesians. Clin Rheumatol 1999; 18: 442-5.
11. Chou CT, Chen JM, Hsu CM, Chen SJ. HLA-B27 and its subtypes in 4 Taiwanese Aborigine tribes: a comparison to Han Chinese patients with ankylosing spondylitis. J Rheumatol 2003; 30: 321-5.
12. Chou CT. HLA-B27 and other related genes in ankylosing spondylitis in APLAR countries. APLAR J Rheumatol 2005; 8: 143-5.
13. Cipriani A, Rivera S, Hassanhi M, Marquez G, Hernandez R, Villalobos C, et al. HLA-B27 subtypes determination in patients with ankylosing spondylitis from Zulia, Venezuela. Hum Immunol 2003; 64: 745-9.
14. Akkoc N, Khan MA. Etiopathogenic role of HLA-B27 alleles in ankylosing spondylitis. APLAR J Rheumatol 2005; 8: 146-53.
15. Gonzalez-Roces S, Alvarez MV, Dieye A, Makni H, Woodfi eld DG, Housan L, et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997; 49: 116-23.
16. Gonzalez S, Garcia-Fernandez S, Martinez-Borra J, Blanco-Gelaz MA, Rodrigo L, Sanchez del Rio J, et al. High variability of HLA-B27 alleles in ankylosing spondylitis and related spondyloarthropathies in the population of northern Spain. Hum Immunol 2002; 63: 673-6.
17. Lee SH, Choi IA, Lee YA, Park EK, Kim YH, Kim KS, et al. Human leukocyte antigen-.B.*2705 is the predominant subtype in the Korean population with ankylosing spondylitis, unlike other Asians. Rheumatol Int 2008; 29: 43-6.
18. Lopez-Larrea C, Sujirachato K, Mehra NK, Chiewslip P, Isarangkura D, Kanga U, et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995; 45: 169-76.
19. Ma HJ, Hu FP. Diversity of human leukocyte antigen-B27 alleles in Han population of Hunan province, southern China. Tissue Antigens 2006; 68: 163-6.
20. Nasution AR, Mardjuadi A, Kunmartini S, Suryadhana NG, Setyohadi B, Sudarsono D, et al. HLA-B27 subtypes positively and negatively associated with spondylarthropathy. J Rheumatol 1997; 24: 1111-4.
21. Oguz FS, Ocal L, Diler AS, Ozkul H, Asicioglu F, Kasapogulu E, et al. HLA-B-27 subtypes in Turkish patients with spondylarthropathy and healthy controls. Dis Markers 2004; 20: 309-12.
22. Olivieri I, Padula A, Ciancio G, Moro L, Durante E, Gaudiano C, et al. The B.*2709 subtype in a patient with undifferentiated spondarthritis. Ann Rheum Dis 2000; 59: 654-6.
23. Paladini F, Taccari E, Fiorillo MT, Cauli A, Passiu G, Mathieu A, et al. Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathy. Arthritis Rheum 2005; 52: 3319-21.
24. Shankarkumar U, Ghosh K, Mohanty D. HLA B27 polymorphism in Western India. Tissue Antigens 2002; 60: 98-101.
25. Varnavidou-Nicolaidou A, Karpasitou K, Georgiou D, Stylianou G, Kokkofi tou A, Michalis C, et al. HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27 related diseases. The possible protective role of B.*2707. Hum Immunol 2004; 65: 1451-4.
26. Ren EC, Koh WH, Sim D, Boey ML, Wee GB, Chan SH. Possible protective role of B.*2706 for ankylosing spondylitis. Tissue Antigens 1997; 49: 67-9.
27. Chen IH, Yang KL, Lee A, Huang H, Lin PY, Lee TD. Low frequency of HLA B.*2706 in Taiwanese patients with ankylosing spondylitis. Eur J Immunogenet 2002; 29: 435-8.
28. Fiorillo MT, Cauli A, Carcassi C, Bitti PP, Vacca A, Passiu G, et al. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with AS in Sardinia implications for disease pathogenisis. Arthritis Rheum 2003; 48: 1385-9.
29. Bosch-Driessen EH, Lardy NM, Rothova A. Antinuclear antibody and HLA-B27 positive uveitis: combination of two diseases? Br J Ophthalmol 1997; 81: 771-3.
30. Konno Y, Numaga J, Tsuchiya N, Ogawa A, Islam SM, Mochizuki M, et al. HLA-B27 subtypes and HLA class II alleles in Japanese patients with anterior uveitis. Invest Ophthalmol Vis Sci 1999; 40: 1838-44.
31. Dunn PP, Day S, Williams S, Bendukidze N. DNA sequencing as a tissue-typing tool. In: NJ Goulding, CG Seward, eds. Pediatric Hematology: Methods and Protocols. Humana Press, Totowa NJ, 2003: 233-46.
32. Albert E, D'Amaro JD, Schipper RF. Population genetics of the human major histocompatibility complex. In: JL Bidwell, C Navarrete, eds. Histocompatibility Testing. Imperial College Press, London, 2000: 395-415.
33. Khan MA, Mathieu A, Sorentino R, Akkoc N. The pathogenic role of HLA-B27 and its subtypes. Autoimmun Rev 2007; 6: 183-9.
34. Marcilla M, Lopez de Castro JA. Peptides: the cornerstone of HLA-B27 biology and pathogenic role in spondyloarthritis. Tissue Antigens 2008; 71: 495-506.
35. Sheehan NJ. The ramifi cations of HLA-B27. J R Soc Med 2004; 97: 10-4.
36. Ramos M, Lopez de Castro JA. HLA-B27 and the pathogenesis of spondyloarthritis. Tissue Antigens 2002; 60: 191-205.
37. Bowness P, HLA B27 in health and disease: a double-edged sword? Rheumatology 2002; 41: 857-68.
38. Schofi eld RH, Warren WL, Koelsch G, Harley JB. A hypothesis for the HLA-B27 immune dysregulation in spondylarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. Proc Natl Acad Sci USA 1993; 90: 9330-4.
39. Mear JP, Schreiber KL, Munz C, Zhu X, Stevanovic S, Rammensee H-G, et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondylarthropathies. J Immunol 1999; 163: 6665-70.
40. Dangoria NS, DeLay ML, Kingsbury DJ, Mear JP, Uchanska- Ziegler B, Ziegler A, et al. HLA-B27 misfolding is associated with aberrant intermolecular disulfi de bond formation (dimerization) in the endoplasmic reticulum. J Biol Chem 2002; 277: 23459-68.
41. Kollnberger S, Bird L, Sun M-Y, Retiere C, Braud VM, McMichael A, et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002; 46: 2972-82.
42. Brown MA, Pile KD, Kennedy LG, Campbell D, Andrew L, March R, et al. A genome-wide screen for susceptibility in loci in ankylosing spondylitis. Arthritis Rheum 1998; 41: 588-95.
43. Brown MA, Pile KD, Kennedy LG Calin A, Darke C, Bell J, Wordsworth BP, et al. HLA-class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996; 55: 268-70.
44. Sims AM, Barnardo M, Herzberg I, Bradbury L, Calin A, Wordsworth BP, et al. Non-B27 MHC associations of ankylosing spondylitis. Genes Immun 2007; 8: 115-23.
45. Lopez-Larrea C, Mijiyawa M, Gonzalez S, Fernandez- Morera JL, Blanco-Gelaz MA, Martines-Borra J, et al. Association of ankylosing spondylitis with HLA-.B.*1403 in a West African population. Arthritis Rheum 2002; 46: 2968-71.
46. Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, Armas, JB, Suarez-Alvarez B, Pruneda L, et al. Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Arthritis Res Ther 2006; 8: R101
47. Niederer R, Danesh-Meyer H. Uveitis screening: HLAB27 antigen and ankylosing spondylitis in a New Zealand population. N Z Med J 2006; 119: U1886.
48. Middleton D. History of DNA typing for the human MHC. Rev immunogenet 1999; 1: 135-56.
49. Seipp MT, Erali M, Wies RL, Wittwer C. HLA-B27 typing: evolution of an allele-specifi c PCR melting assay and two fl ow cytometric antigen assays. Cytometry B Clin Cytom 2005; 63: 10-5.
50. Voorter CE, van der Vlies SA, van den Berg-Loonen EM. Sequence-based typing of HLA-B: the B7 cross-reacting group. Tissue Antigens 2000; 56: 356-62.
51. Voorter CE, Swelsen WT, van den Berg-Loonen EM. B.*27 in molecular diagnostics: Impact of new alleles and polymorphism outside exons 2 and 3. Tissue Antigens 2002; 60: 25-35.
52. www.stats.govt.nz/ last accessed 29/09/2009
53. Khan MA. Update: the twenty subtypes of HLA-B27. Curr Opin Rheumatol 2000; 12: 235-8.
54. Ball EJ, Khan MA. HLA-B27 polymorphism. Joint Bone Spine 2001; 68: 378-82.
55. Yang KL, Chen IH, Hsiao CK, Cherng JM, Yang KZ, Chang CC, et al. Polymorphism of HLA-B27 in Taiwanese Chinese. Tissue Antigens 2004; 63: 476-9.
56. Dhaliwal JS, Too CL, Lisut M, Lee YY, Murad S. HLAB27 polymorphism in the Malays. Tissue Antigens 2003; 62: 330-2.
57. Chhaya SU. HLA-B27 polymorphism in Mumbai, Western India. Tissue Antigens. 2005; 66: 48-50.
58. Friedlaender JS, Friedlaender FR, Reed FA, Kidd KK, Kidd JR, Chambers GK et al. The genetic structure of Pacifi c Islanders. PLoS Genet 2008; 4: e19.
59. Sudarsono D, Hadi S, Mardjuadi A, Nasution AR, Dekker- Saeys AJ, Breur-Vriesendorp BS et al. Evidence that HLA-.B.*2706 is not protective against spondylarthropathy. J Rheumatol 1999; 26: 1534-6.
60. Montserrat V, Marti M, Lopez de Castro JA. Allospecifi c T cell epitope sharing reveals extensive conservation of the antigenic features of peptide ligands among HLA-B27 subtypes differentially associated with spondyloarthritis. J Immunol 2003; 170: 5778-85.
61. Lamas J, Paradela A, Roncal F, Lopez de Castro JA. Modulation at multiple anchor positions of the peptide specifi city of HLA-B27 subtypes differentially associated with ankylosing spondylitis. Arthritis Rheum 1999; 42: 1975-85.
62. Fiorillo MT, Cauli A, Carcassi C, Bitti PP, Vacca A, Passiu G, et al. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia implications for disease pathogenisis. Arthritis Rheum 2003; 48: 1385-9.
63. Cascino I, Paladini F, Belfi ore F, Cauli A, Angelini C Fiorillo MT, et al. Identifi cation of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia. Arthritis Rheum 2007; 56: 2640-51.
64. Hulsmeyer M, Hillig RC, Volz A, Ruhl M, Schroder W, Saenger W, et al. HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J Biol Chem 2002; 277: 47844-53.
65. Fabian H, Huser H, Narzi D, Misselwitz R, Loll B, Ziegler A, et al. HLA-B27 subtypes differentially associated with disease exhibit conformational differences in solution. J Mol Biol 2008; 376: 798-810.
66. Giquel B, Carmouse S, Denais C, Cherfa A, Chimenti M-S, Fert I, et al. Two HLA-B27 alleles differently associated with spondylarthritis, B.*2709 and B.*2705, display similar intracellular traffi cking and oligomer formation. Arthritis Rheum 2007; 56: 2232-43.
67. Goodall JC, Ellis L, Hill Gaston JS. Spondylarthritisassociated and non-spondylarthritis-associated B27 subtypes differ in their dependence upon tapasin for surface expression and their incorporation into the peptide loading complex. Arthritis Rheum 2006; 54: 138-47.
68. Gomez P, Montserrat V, Marcilla M, Paradela A, Lopes de Castro, JA. B.*2707 differs in peptide specifi city from B.*2705 and B.*2704 as much as from HLA-B-27 subtypes not associated to spondyloarthritis. Eur J Immunol 2006; 36: 1867-81.
69. Galocha B, Lopez de Castro JA, Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and show incomplete correspondence to ankylosing spondylitis. Arthritis Rheum 2008; 58: 401-12.
70. Suarez-Almazor ME, Russell AS. B27 homozygosity and ankylosing spondylitis. J Rheumatol 1987; 14: 302-4.
71. Jaakkola E, Herzberg I, Laiho K, Barnardo MC, Pointon JJ, Kauppi M, et al. Finnish HLA studies confi rm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis 2006; 65: 775-80.
72. Sachs J, Festenstein H. Associated clinical syndromes in a patient homozygous for HLA B27. Br Med J 1978; 1 (6121): 1184-5.